Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics Inc (NQ: NRIX )

12.00 -0.47 (-3.77%)
Streaming Delayed Price Updated: 2:54 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 389,012
Open 12.25
Bid (Size) 12.00 (4)
Ask (Size) 12.03 (3)
Prev. Close 12.47
Today's Range 11.95 - 12.50
52wk Range 4.220 - 18.12
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+17.42%
+17.42%
1 Month
-17.70%
-17.70%
3 Month
+43.37%
+43.37%
6 Month
+128.14%
+128.14%
1 Year
+21.21%
+21.21%

More News

Read More
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
Via Benzinga
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Decoding 4 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
The Latest Analyst Ratings for Nurix Therapeutics
Via Benzinga
What 4 Analyst Ratings Have To Say About Nurix Therapeutics
Via Benzinga
NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
From Toll Brothers, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Via Benzinga
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
Via Benzinga
Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.